Serum choline in extremely preterm infants declines with increasing parenteral nutrition

Anders K Nilsson1, Anders Pedersen2, Daniel Malmodin2

  • 1Section for Ophthalmology, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. anders.k.nilsson@gu.se.

Insights

Parenteral fluids negatively impact free choline levels in extremely preterm infants. Lower choline concentrations were observed with higher fluid intake, affecting infant development.

Area of Science:

  • Neonatal nutrition
  • Nutrient metabolism in preterm infants
  • Biochemical markers in neonates

Background:

  • Choline is vital for fetal and infant development.
  • Neonatal parenteral nutrition (PN) often lacks sufficient free choline.
  • PN may contain lipid-bound choline (phosphatidylcholine).

Purpose of the Study:

  • To investigate serum free choline, betaine, and methionine levels in extremely preterm infants.
  • To determine how parenteral fluid intake affects these nutrient concentrations.
  • To track longitudinal changes in these metabolites during the first 28 postnatal days and beyond.

Main Methods:

  • Prospective study of 87 infants with gestational age < 28 weeks.
  • Serum samples collected at multiple time points: PND 1, 7, 14, 28, and PMA 32, 36, 40 weeks.
  • Quantification of free choline, betaine, and methionine using 1H NMR spectroscopy.

Main Results:

  • Initial serum free choline at PND 1 was 33.7 µM, decreasing sharply by PND 7 to 18.4 µM.
  • Choline levels increased post-PND 7 but did not reach initial levels.
  • Higher parenteral fluid intake correlated negatively with serum free choline concentrations.

Conclusions:

  • Parenteral fluid administration significantly impacts circulating free choline levels in extremely preterm infants.
  • The proportion of parenteral fluids is a key factor influencing choline status.
  • Further research may be needed to optimize PN for choline delivery in this vulnerable population.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
541
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
121
Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
3.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
161
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
182
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
491